Letter from the CEO - EpiFinder

Letter from the CEO


Epilepsy is a neurologic disorder where individuals suffer from uncontrollable seizure episodes. Over 3.4 million people live with the condition, and it can affect 1 in 26 people at some point in their lifetime.  Correctly gathering information and identifying or diagnosing whether someone has epilepsy or not or what type of epilepsy they have is important in the management or treatment of their epilepsy which helps to control their seizures.  

Unfortunately, most individuals with epilepsy do not have their seizures properly evaluated and controlled.  In April of 2012 a report by the Institute of Medicine (IOM), “Epilepsy Across the Spectrum,” identified that standard definitions and guidelines towards the assessment of epilepsy syndromes do not exist.  As a result, most patients with epilepsy cannot be diagnosed with their particular epileptic syndrome with up to 40% found to have epilepsy misdiagnosed. The report found that the lack of standard definitions and guidelines affects the proper education and training of healthcare professionals that encounter people with epilepsy.

At EpiFinder, we have been developing standard definitions, concepts, and guidelines in epilepsy by taking all the latest information in the epilepsy domain and incorporating it in our artificial intelligence clinical decision support tool.  We have been working closely with neurologists at Mayo Clinic in Arizona who have validated our standards and evaluated our tool.

As a company, our goal is to provide our tool to all the healthcare professionals that encounter, deal with, and manage those individuals with epilepsy.  By becoming a member of EpiFinder, you join the others who are at the cutting edge of medicine and technology that help to improve our knowledge base of epilepsy, and ultimately, improve patient outcomes and lives.  Please download the app and try it today.

By joining EpiFinder, you are helping us send a signal to the industry that health care professionals want to improve patient outcomes.


Robert Yao